TREATMENT

Clinical trials for TREATMENT explained in plain language.

Never miss a new study

Get alerted when new TREATMENT trials appear

Sign up with your email to follow new studies for TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

New drug combo aims to boost platelets in Hard-to-Treat ITP

Disease control Recruiting now

This study tests whether combining two drugs—rituximab and daratumumab—can safely raise platelet counts in adults with immune thrombocytopenia (ITP) who no longer respond to steroids. About 20 participants will receive the combination and be monitored for 12 weeks. The goal is to…

Matched conditions: TREATMENT

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Apr 29, 2026 15:04 UTC

TREATMENT

Get alerted when new TREATMENT trials appear

New drug combo aims to boost platelets in Hard-to-Treat ITP